Author:
Xu WenQing,Bai Qingke,Dong Qiang,Guo Min,Cui Mei
Abstract
Chronic cerebral hypoperfusion (CCH) is a major cause of vascular cognitive impairment and dementia (VCID). Although the underlying mechanisms have not been fully elucidated, the emerging data suggest that blood–brain barrier (BBB) dysfunction is one of the pivotal pathological changes in CCH. BBB dysfunction appears early in CCH, contributing to the deterioration of white matter and the development of cognitive impairment. In this review, we summarize the latest experimental and clinical evidence implicating BBB disruption as a major cause of VCID. We discuss the mechanisms of BBB dysfunction in CCH, focusing on the cell interactions within the BBB, as well as the potential role of APOE genotype. In summary, we provide novel insights into the pathophysiological mechanisms underlying BBB dysfunction and the potential clinical benefits of therapeutic interventions targeting BBB in CCH.
Subject
Cellular and Molecular Neuroscience
Reference98 articles.
1. Blood-brain barrier dysfunction in Binswanger’s disease; an immunohistochemical study.;Akiguchi;Acta Neuropathol.,1998
2. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises.;Armulik;Dev Cell,2011
3. Role of the CNS microvascular pericyte in the blood-brain barrier.;Balabanov;J. Neurosci. Res.,1998
4. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.;Bell;Nature,2012
5. Complement C3a Receptor (C3aR) Mediates Vascular Dysfunction, Hippocampal Pathology, and Cognitive Impairment in a Mouse Model of VCID.;Bhatia;Transl. Stroke Res.,2022
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献